NCMAG 129 Aspirin: October 2026
Posted on:
Document Type
NCMAG advice
Process guidance
Summary
For the adjuvant treatment of adults with resected stage I to III rectal cancer or stage II to III colon cancer with PI3K pathway alterations.
Decision: off-label use is supported